OC-0515 NBTXR3 activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients. (August 2021) - Le Tourneau, C.; Calugaru, V.; Takacsi-Nagy, Z.; Liem, X.; Papai, Z.; Moreno, V.; Braña, I.; Salas, S.; Poissonnet, G.; Calvo, E.; Doger, B.; Choussy, O.; et al.